European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. 26 April, 2016.

Food and Drug Administration 96

Food and Drug Administration Pharmaceutical products Pharmaceutical FDA 96

European Pharmaceutical Review

NOVEMBER 24, 2022

The number of unauthorised and unregulated online outlets selling counterfeit pharmaceutical products is continuously growing, with many selling counterfeit medications via the internet typically posing as legitimate vendors. Covert-hologram seals are also atracting interest within the pharmaceutical packaging sector.

Pharmaceutical 111

Pharmaceutical Manufacturing Pharmaceutical products Distribution 111

Pharmaceutical Technology

OCTOBER 28, 2022

Quality by design (QbD) is a concept introduced into the pharmaceutical regulatory lexicon in 2005. QbD principles are woven into regulatory guidance documents, primarily guidances Q8 to Q11 of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

Manufacturing 52

Manufacturing Safety Medicine Pharmaceutical 52

European Pharmaceutical Review

DECEMBER 19, 2023

A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient. About 800 million humans are injected with vaccines every year” Most vaccines in use today are relatively cheap to make and are injected into patients with mass‑produced and inexpensive (five-cent) disposable syringes.

Distribution 111

Distribution Manufacturing Food Pharmaceutical 111